Phillip Securities Group
Please note that the Day Light Saving of Europe and US will be effective on April 1st and March 11th respectively. The trading hours for those relevant contracts will be 1 hour earlier. Any questions, please contact us at 22776677.For details, please visit our foreign futures website or contact us at 22776677.Moreover,the spread of USD/JPY is low as one pip.Please click here for details
  Phillip Investor Notes

23-11-2020(Mon) 20-11-2020(Fri) 19-11-2020(Thu) 18-11-2020(Wed) 17-11-2020(Tue)
Page : 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 |
Investor Notes - Phillip Securities (HK) Ltd
Past Investor Notes  
Phillip Home Send to Friends Free Subscription Give Comments ¤¤¤åª©
12 Oct, 2020 (Monday)

Xinjiang Goldwind Science & Technology Co. (2208) is involved in the following principal activities: manufacture and sale of wind turbine generators and wind power components; provision of wind power related consultancy, wind farm construction and maintenance services; development and operation of wind farms. In August 2020, the Group`s first turbine in Yangjiang wind power base was officially launched, and marking the official commencement of large-scale development of construction in Yangjiang. On top of Yangjiang base, the Company will build the largest offshore wind power industry cluster in the southern region, and will build a wind power equipment manufacturing base that "centers Guangdong, spreads to Guangxi and Hainan, and embraces Southeast Asia". Currently, the Group`s wind farm asset management capacity in China totaled 5,755.4MW. A steady increase in cumulative wind installation capacity will bring about growth opportunities in wind power post-warranty service business. (I do not hold the above stock)
Buy-in Price: $7.60, Target Price: $8.80, Cut Loss Price: $7.10

Powerlong Real Estate Holdings Limited focuses on the development and operation of high-quality, large-scale and multi-format commercial real estate projects. As of June 30 2020, the company has developed, owned and operated 155 property development projects. Among them, Powerlong Plaza, which integrates shopping, catering, leisure and other entertainment facilities, has formed a unique commercial real estate model and obtained various Wide attention and recognition from the government and the public. Each project not only stimulated the development of the local economy, but also improved the retail facilities in the local city, provided many employment opportunities for the society, realized people`s needs and dreams for life, and improved the style of the city. The company announced on October 8 that the contracted sales for September this year was 8.102 billion RMB, an increase of about 56.1% year-on-year; the contracted sales area was 525,700 square meters. The company said that under the epidemic, it still achieved an increase in the total contracted sales and is confident of achieving the contracted sales target of 75 billion RMB this year. We are optimistic about its long-term development.
Buy-in Price: $6.00, Target Price: $6.90, Cut Loss Price: $5.40

Aoyuan Healthy (3662 HK) - Multiple engines driven simultaneously

Investment Summary

On September 18, 2020, Aoyuan Healthy announced the acquisition of Zhejiang Liantianmei Corporate Management Company Limited (®ý¦¿³s¤Ñ¬ü¥ø·~ºÞ²z¦³­­¤½¥q) 55% equity, together with the company's 5% equity acquired in March this year, the company holds a total of 60% equity in the target company. The cash consideration is capped at RMB 691 million. The consideration will be divided into three phases. The company has paid a total of RMB 374 million for the first two phases, and the balance of the remaining consideration in the third phase will be paid on or before March 31, 2021. The total consideration will be based on Liantianmei's 2020 net profit calculated at 16.66x P/E, the valuation is reasonable.

Changes in the company's revenue structure and increased business GPM

The company completed the strategic deployment of its medical beauty sector through acquisitions and formed synergy with other businesses. The acquired company has two private medical beauty hospitals in Hangzhou, with a total operating area of approximately 30,000 sqm, both of which have been awarded 5A Rating Management Standard and possess the operational qualifications for standardized medical institutions. The number of employees is 626, including 73 doctors, 94 nurses and 7 pharmacists. The business includes plastic surgery, micro plastic surgery, dermatology, dentistry, hair transplantation, Chinese medicine and life beauty, etc., mainly services with higher technical barriers.

The average turnover of Liantianmei in the past two fiscal years was approximately RMB 470 million. However, the company has made compliance adjustments and expanded new hospitals in the past two years, resulting in a decline in annual profits. It is expected that as the target company's integration work is completed, profitability will increase. In the first half of 2020, it will record a turnover of RMB 210 million and a net profit of RMB 46.16 million, reflecting the target company's ability to control costs and demand for medical beauty services toughness. The company has more than 300,000 customers, of which long-term customers account for a relatively large proportion, indicating that the business is sticky. The acquisition target is expected to contribute more than 5,000 equity net profits next year.

The consideration for the acquisition is capped at 691 million, that is, if the net profit of the acquisition target in 2020 exceeds 75 million, the upper limit consideration will be required. We expect the net profit target to be achieved. In terms of acquisition funds, the company reallocates the net proceeds from the global offering for the intended use, and reallocates the remained funds originally intended for other purposes to acquisition or investment in service providers providing services complementary to the Group's commercial operational services and property management services, the remained net balance used to acquire health medical beauty service providers after reallocation is RMB 215 million. The company also considers financing through annexation loan, but will take into account the company's overall leverage.

Three business sectors archive synergy

Aoyuan Healthy has further acquired Liantianmei and completed its deployment in the medical beauty sector. In the future, through Aoyuan Healthy's community as an entrance, on the one hand, it has a large group of owners as potential customers, on the other hand, it has a wealth of offline advertising resources and commercial areas, which help Liantianmei reduce sales costs and introduce passenger flow. At the same time, Aoyuan Healthy's property and commercial services cover major areas such as the Greater Bay Area, Beijing Rim, Central China and East China, which will help Liantianmei further expand its scope of influence. We believe that the acquisition enables the company to open up a new blue ocean in addition to traditional property management services, and to further provide the company with sustained revenue growth through community traffic through community VAS.

Investment Thesis

As the acquisition of Liantianmei provides the company with further growth momentum, we have revised our previous forecasts and raised the company's 2020E 2021E EPS to RMB 35.60 cent and RMB 52.43 cent, considering that the company's contribution to revenue after the acquisition will begin to be significant next year, and maintain FY21E target P/E ratio, raise the target price of HK$10.72 to correspond to the 26.50/19.7x P/E for 2020E and 2021E, and maintain the BUY rating.(Current price as of October 7)

Peer Comparison


Click Here for PDF format...

Recommendation on 12-10-2020
Price on Recommendation Date$ 6.210
Suggested purchase priceN/A
Target Price$ 10.720
Writer Info
Timothy Chong
(Research Analyst)
Tel: (+ 852 2277 6515)

Local Index
       Index    Change   Change%

World Index
       Index    Change   Change%

A-H spread
Stock Code H share
A share
H share

Oversea Research Reports

Investment Service Centre

Enquiry : 2277 6666 OR
If you cannot read this e-mail in the proper format, please click here to view the web version.

Information contained herein is based on sources that Phillip Securities (Hong Kong) Limited and/or its affiliates ( the ¡§Group¡¨) believe to be accurate. The Group does not bear responsibility for any loss occasioned by reliance placed upon the contents hereof. The Group (or its employees) may have interests in relevant investment products. For details of different products¡¦ risks, please view the Risk Disclosures Statement on

If you DO NOT wish to receive further marketing emails from us, please click HERE to opt-out.

ª©Åv©Ò¦³¡A ½¦L¥²¨s¡C

Copyright(C) 2020 Phillip Securities (HK) Ltd. All Rights Reserved.

Copyright © 2011 Phillip Securities Group. All Rights Reserved [ Risk Disclosures Statement ] [ Terms and Conditions ] [ Personal Data Policy ]